President Donald Trump announced a major initiative aimed at lowering the cost of popular weight loss drugs in the U.S. Pres. Trump unveiled deals with Eli Lilly and Novo Nordisk to reduce prices on Wegovy (Novo Nordisk), Zepbound (Eli Lilly) and potential inclusion of Ozempic, primarily a diabetes drug also used for weight loss.

Please Like, Comment and Follow 'Broeske & Musson' on all platforms:   

---    

The ‘Broeske & Musson Podcast’ is available on the KMJNOW app, Apple Podcasts, Spotify or wherever else you listen to podcasts.    

---  

‘Broeske & Musson'  

Weekdays 9-11 AM Pacific on News/Talk 580 AM & 105.9 FM KMJ  

| Facebook | Podcast| X |   

-  

Everything KMJ   

KMJNOW App | Podcasts | Facebook | X | Instagram    

See omnystudio.com/listener for privacy information.